Acceleron and fulcrum therapeutics announce pulmonary research and discovery collaboration agreement

Acceleron and fulcrum therapeutics announce pulmonary research and discovery collaboration agreement.acceleron pharma- fulcrum to receive $10 million upfront payment, be eligible for future milestone payments.acceleron pharma - fulcrum will additionally receive tiered royalty payments in mid-single-digit to low double-digit range on net sales.acceleron pharma - will be responsible for development, commercialization activities for any potential therapeutics identified via fulcrum's platform.acceleron pharma - fulcrum to receive up to of $143.5 million in additional milestone payments for all subsequent products commercialized.acceleron pharma - fulcrum will also be eligible to receive research and development & commercial milestone payments of up to $295 million for a first product commercialized.
FULC Ratings Summary
FULC Quant Ranking